Skip to content

Operative management of 281 Achilles tendon ruptures ;a 10 year clinical retrospective analysis

Operative management of 281 Achilles tendon ruptures ;a 10 year clinical retrospective analysis - Achilles tendon rupture case series

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON38370
Enrollment
281
Registered
2014-01-29
Start date
2014-02-12
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

achilles tendon rupture rupture of the achilles tendon

Interventions

None listed

Sponsors

Onze Lieve Vrouwe Gasthuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients treated in the period 2002-2012 for a complete rupture of the achilles tendon at the OLVG. Age : 18-65 Years Treatment initiated

Exclusion criteria

Exclusion criteria: - rerupture/ bilateral rupture/ open rupture - combination of rupture with a fracture of the foot/ankle - previous treatment with local anestethics - fysical/mental handicaps that may possibly interfer with follow-up - APR treated with conservative treatement

Design outcomes

Primary

MeasureTime frame
Rerupure rates, complications and active range of motion of the anke of patients surgically treated for a Achilles tendon rupture.

Secondary

MeasureTime frame
Patient satisfaction scores and subjective and objective function scores for patients surgically treated for Achilles tendon rupture using the following scoring systems: VISA-A,VAS, ATTRS, Leppilathi, SF12. Other parameters: The following baseline values will be collected: - DVT - pulmonary embolism - fluorquinolones/steroid use - diabetes, cardiovascular disease, smoking - sport and level of practice - age - gender - weight/height The following injury related values will be collected: - affected side - pre-existent achillotendinopathie - wound infection (superficial/deep) - nerve damage (n.suralis) - calf circumference - active range of motion - muscle strength - time until OK

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)